Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-27 Sale | 2024-12-31 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 354,604 | $11.68 | $4,141,662 | 24,443,444 (Direct) | View |
| 2024-12-23 Sale | 2024-12-26 9:00 pm | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 886,237 | $12.01 | $10,641,739 | 66,074,572 (Direct) | View |
| 2024-12-20 Sale | 2024-12-26 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $11.49 | $1,149,000 | 12,821,814 (Direct) | View |
| 2024-12-18 Sale | 2024-12-20 9:00 pm | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 412,584 | $12.05 | $4,971,637 | 34,947,147 (Direct) | View |
| 2024-11-20 Sale | 2024-11-22 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $11.32 | $1,132,000 | 12,932,759 (Direct) | View |
| 2024-10-21 Sale | 2024-10-22 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $11.65 | $1,165,000 | 13,043,704 (Direct) | View |
| 2024-09-25 Sale | 2024-09-26 9:22 pm | Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director | 926,000 | $11.82 | $10,942,820 | 65,793,779 (Indirect) | View |
| 2024-09-24 Sale | 2024-09-26 8:35 pm | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 503,000 | $11.66 | $5,866,308 | 1,277,178 (Direct) | View |
| 2024-09-24 Sale | 2024-09-26 8:34 pm | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 4,426,000 | $11.71 | $51,820,727 | 26,911,188 (Indirect Direct) | View |
| 2024-09-23 Sale | 2024-09-24 9:01 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 1,983,257 | $11.79 | $23,382,600 | 32,843,727 (Direct) | View |
| 2024-09-23 Sale | 2024-09-24 9:01 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 250,000 | $11.89 | $2,972,500 | 709,322 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-28 Tax Withholding | 2024-12-31 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,896 | $11.8 | 272,576 (Direct) | View |
| 2024-12-27 Exercise | 2024-12-31 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 500,000 | $0 | 24,443,444 (Direct) | View |
| 2024-12-27 Exercise | 2024-12-31 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 500,000 | $3.85 | 24,443,444 (Direct) | View |
| 2024-12-23 Exercise | 2024-12-26 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 886,237 | $0 | 66,074,572 (Direct) | View |
| 2024-12-23 Exercise | 2024-12-26 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 886,237 | $3.85 | 66,074,572 (Direct) | View |
| 2024-12-20 Tax Withholding | 2024-12-26 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,129 | $11.57 | 274,472 (Direct) | View |
| 2024-12-20 Tax Withholding | 2024-12-26 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 3,087 | $11.57 | 204,321 (Direct) | View |
| 2024-12-20 Exercise | 2024-12-26 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $0 | 12,821,814 (Direct) | View |
| 2024-12-20 Tax Withholding | 2024-12-26 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 10,945 | $11.57 | 12,821,814 (Direct) | View |
| 2024-12-20 Exercise | 2024-12-26 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $3.85 | 12,821,814 (Direct) | View |
| 2024-12-20 Tax Withholding | 2024-12-26 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11.57 | 17,339,169 (Direct) | View |
| 2024-12-18 Exercise | 2024-12-20 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 412,584 | $0 | 34,947,147 (Direct) | View |
| 2024-12-18 Exercise | 2024-12-20 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 412,584 | $3.85 | 34,947,147 (Direct) | View |
| 2024-12-03 Other | 2024-12-05 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 3,651,985 | $12.21 | 22,488,532 (Direct) | View |
| 2024-11-28 Tax Withholding | 2024-12-02 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,341 | $12.69 | 276,601 (Direct) | View |
| 2024-11-20 Tax Withholding | 2024-11-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 958 | $11.49 | 207,408 (Direct) | View |
| 2024-11-20 Exercise | 2024-11-22 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $0 | 12,932,759 (Direct) | View |
| 2024-11-20 Tax Withholding | 2024-11-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 10,945 | $11.49 | 12,932,759 (Direct) | View |
| 2024-11-20 Exercise | 2024-11-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $3.85 | 12,932,759 (Direct) | View |
| 2024-11-20 Tax Withholding | 2024-11-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11.49 | 17,350,114 (Direct) | View |
| 2024-10-28 Tax Withholding | 2024-10-30 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,341 | $11.84 | 278,942 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 1,231 | $0 | 93,665 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 1,613 | $0 | 38,037 (Direct) | View |
| 2024-10-21 Option Award | 2024-10-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 2,303 | $0 | 97,856 (Direct) | View |
| 2024-10-21 Exercise | 2024-10-22 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $0 | 13,043,704 (Direct) | View |
| 2024-10-20 Tax Withholding | 2024-10-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 10,945 | $11.92 | 13,043,704 (Direct) | View |
| 2024-10-21 Exercise | 2024-10-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 100,000 | $3.85 | 13,043,704 (Direct) | View |
| 2024-10-20 Tax Withholding | 2024-10-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 956 | $11.92 | 208,366 (Direct) | View |
| 2024-10-20 Tax Withholding | 2024-10-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11.92 | 17,361,059 (Direct) | View |
| 2024-09-28 Tax Withholding | 2024-10-01 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,340 | $11.48 | 281,283 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-24 9:01 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 1,550,000 | $0 | 32,843,727 (Direct) | View |
| 2024-09-23 Other | 2024-09-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 498,539 | $11.97 | 32,843,727 (Direct) | View |
| 2024-09-20 Tax Withholding | 2024-09-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,945 | $11.97 | 32,843,727 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 1,550,000 | $3.85 | 32,843,727 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-24 9:01 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 250,000 | $0 | 709,322 (Direct) | View |
| 2024-09-20 Tax Withholding | 2024-09-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 3,087 | $11.97 | 709,322 (Direct) | View |
| 2024-09-23 Exercise | 2024-09-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 250,000 | $3.85 | 709,322 (Direct) | View |
| 2024-09-20 Tax Withholding | 2024-09-24 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,129 | $11.97 | 283,623 (Direct) | View |
| 2024-09-20 Tax Withholding | 2024-09-24 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 10,945 | $11.97 | 628,415 (Direct) | View |
| 2024-09-12 Other | 2024-09-16 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 3,487 | $12.12 | 99,040 (Direct) | View |
| 2024-09-12 Other | 2024-09-16 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 3,056 | $12.12 | 95,490 (Direct) | View |
| 2024-09-12 Other | 2024-09-16 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 4,245 | $12.12 | 40,669 (Direct) | View |
| 2024-09-12 Other | 2024-09-16 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 2,599 | $12.12 | 9,947,937 (Direct) | View |
| 2024-09-12 Other | 2024-09-16 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 894 | $12.12 | 30,270 (Direct) | View |
| 2024-09-10 Option Award | 2024-09-12 9:00 pm | N/A 2034-09-09 | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 44,300 | $0 | 9,975,831 (Direct) | View |
| 2024-09-10 Option Award | 2024-09-12 9:00 pm | N/A 2034-09-09 | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 44,300 | $0 | 1,808,072 (Direct) | View |
| 2024-09-10 Option Award | 2024-09-12 9:00 pm | N/A 2034-09-09 | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 44,300 | $0 | 68,563 (Direct) | View |
| 2024-09-10 Option Award | 2024-09-12 9:00 pm | N/A 2034-09-09 | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 44,300 | $0 | 58,164 (Direct) | View |
| 2024-09-10 Option Award | 2024-09-12 9:00 pm | N/A 2034-09-09 | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 44,300 | $0 | 126,934 (Direct) | View |
| 2024-09-10 Option Award | 2024-09-12 9:00 pm | N/A 2034-09-09 | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 44,300 | $0 | 123,384 (Direct) | View |
| 2024-08-28 Tax Withholding | 2024-08-30 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,341 | $12 | 285,752 (Direct) | View |